Notably, the CML + Vit-C group revealed an IL-6-stained area of around 13.5%, demonstrating a significant 60% reduction (p < 0.001) compared to the CML + PBS group. The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.